Johnson and Johnson Company Profile
Risperdal is a Johnson and Johnson antipsychotic drug that may tarnish the once clean reputation of the giant drug company. If you would like to make a claim for side effects, contact us today!
Johnson & Johnson is a multinational manufacturer of pharmaceutical drugs and medical devices, and the New Jersey-based company was founded back in 1886. Since that time, Johnson & Johnson has established itself as a household name among consumers throughout the United States, introducing such trusted products as Tylenol pain reliever, Neutrogena skin care products, the Band-Aid brand of bandages, and many more. It is this long-standing trust in the company that has resulted in consumers using and doctors prescribing the products more recently developed by Johnson & Johnson, including the drug firm’s antipsychotic medication Risperdal. However, the company’s once stellar reputation has taken a major hit in recent years, as product recalls, fines for illegal marketing practices and other legal issues have raised serious concerns about the safety and efficacy of some of J&J’s most popular medical devices and medications, including Risperdal.
Johnson & Johnson’s Risperdal Antipsychotic
In addition to a number of other prescription and over-the-counter medications, Johnson & Johnson is responsible for manufacturing the atypical antipsychotic drug Risperdal (risperidone). Since its introduction in 1993, Risperdal has become one of the most widely used antipsychotic medications on the market in the United States, representing a whopping 23% of the 54 million antipsychotic prescriptions filled in the 12 month period ending in October 2011. Despite its popularity as a treatment for schizophrenia, bipolar disorder and other psychiatric disorders, however, mounting research has identified Risperdal use as a possible risk factor for a number of devastating side effects, including heart attack, stroke, tardive dyskinesia and gynecomastia (male breast growth).
J&J’s Risperdal Marketing Practices
As more information is brought to light about the risk of Risperdal side effects, serious concerns are being raised about Johnson & Johnson’s marketing practices with regards to its Risperdal antipsychotic. In fact, J&J has already settled a number of lawsuits and paid millions of dollars in fines over allegations that the drug company deceptively marketed Risperdal to consumers and healthcare providers, and in early 2012, agreed to pay as much as $2.2 billion to resolve Justice Department probes into its sales practices for Risperdal and other medications. In August 2012, Johnson & Johnson was ordered to pay another $181 million to settle claims by 36 states that the drug firm improperly promoted and advertised Risperdal and other antipsychotic medication called Invega. At that time, this settlement represented the largest multi-state consumer protection-based drug settlement in history.
Johnson & Johnson Product Recalls
One of the first, and certainly the most devastating, recall affecting a Johnson & Johnson product was the nationwide recall of 31 million bottles of Tylenol in 1982. The recall came after the first of seven individuals died in Chicago, after ingesting Extra Strength Tylenol that had been deliberately laced with cyanide. Dubbed the “Tylenol murders,” this action marked one of the first major recalls in American history, and played an important role in federal anti-tampering laws and reforms in the packaging of over-the-counter products like Tylenol pain reliever.
In April 2010, J&J subsidiary McNeil Consumer Healthcare recalled 43 over-the-counter children’s medications, including Tylenol and Benadryl, after a routine inspection of a Pennsylvania manufacturing facility found that some “products may not fully meet the required manufacturing specifications.” According to federal investigators, the products affected by the recall may have contained a “higher concentration of active ingredients” or exhibited other manufacturing defects, which could have put consumers at unnecessary risk for side effects.
Another major recall affecting a Johnson & Johnson product came in August 2010, when the company recalled its ASR metal-on-metal hip implant after research found a higher-than-expected failure rate with the medical device. According to data from the National Joint Registry, 12-13% of patients who received an ASR hip replacement system required revision surgery after five years, which was significantly higher than the failure rate previously reported by Johnson & Johnson. Side effects of the recalled hip implant, including soft tissue damage and long-term disability, have led to many affected consumers filing product liability lawsuits against Johnson & Johnson.
Risperdal Lawsuits Filed Against J&J
As Johnson & Johnson continues to face claims filed on behalf of consumers who have been affected by the ASR hip implant and other potentially defective products, the most recent litigation affecting the drug company involves its Risperdal antipsychotic medication, first introduced by J&J in 1993. Juries in several U.S. states have found Johnson & Johnson guilty of concealing information regarding the side effects of Risperdal, manufactured by the company’s Janssen Pharmaceuticals subsidiary, in order to market the medication to consumers and the medical community as safer and more effective than cheaper generic antipsychotics. States that have already awarded damages in regards to J&J’s Risperdal marketing practices include Arkansas ($1.2 billion), Louisiana ($258 million), South Carolina ($327 million) and Texas ($158 million). In light of these actions, the Attorney General concluded, “These two companies put profits before people, and they are rightfully being held responsible for their actions.”